Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: TWICK who wrote (15663)	9/26/1998 5:27:00 PM
From: Jenna	Read Replies (2) \| Respond to of 120523

continuation- DRTE, RXSD, BRKS RXSD.. is highly oversold, stochastic between 5 and 10.. Earnings are what is important in deciding if RXSD becomes a buy for more than a daytrade, rumours flying as to the quality of their drugs. Company says it will meet estimates, rumours have it they won't. RXSD has to put it mildly, a very bad chart. CCI and MACD actually had sell signals in the last 3 trading sessions, RSI is perhaps a bit higher than it was at the stocks low and Money flow index is sloping positively. Earnings out on October 7, giving you ample time to watch for a change of trend. If and only IF earnings are good there is a chance the stock will reach its estimated 'valuations'.. If not be prepared for a further tanking. 25% of this stock is being shorted. Luckily, you will soon have your answers.. If you buy on 'anticipatory upswing' you will know in the next 1-3 trading sessions if stochastics turn bullish and volume and price increase. DRTE... one of my new 'favorites'.... AA+ rating by MPT review, AA by OTC Insight, 99 relative strength ranking 29% earnings surprise last quarter. Chart is excellent with MACD bullish and Relative strength bullish.. but Stochastic suggest DRTE is overbought. DRTE has earnings out on the 14th of October.. It would be very attractive as an earnings play especially if it pulls back. Earnings Velocity: $11 cents last quarter to $0.13 estimated this quarter to $0.15 next quarter....DRTE has very positive fundamentals. It's success already established in this country now its successful abroad as well: Dendrite's European Success Further Accelerated Kronenbourg, Evian, and William Pitters License Dendrite's ForceOne Solution MORRISTOWN, N.J.--(BUSINESS WIRE)--Aug. 20, 1998-- Dendrite International Inc. (NASDAQ/NMS:DRTE - news), the leading supplier of enterprise-wide sales force effectiveness solutions for the pharmaceutical and Consumer Packaged Goods (CPG) industries, today announced the signing of three new CPG clients in France - Kronenbourg, Evian, and William Pitters. BRKS.. wow.. poor chart.. Stochastics are overbought, looks like people are expecting this to recover sometimes.. Looks to be losing money in the next year.. perhaps recovering by 3rd quarter of 1999. Looks like this can be on our list of low-priced stocks that will give 15-20% on any bounce... I would buy 1,000 shares of this and sit on in for 12-18 months.

To: TWICK who wrote (15663)	9/26/1998 5:43:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

RXSD..nothing wrong with your analysis! My only problem with RXSD is that lately I'm looking to hold stocks for 10-40% gains in 2-14 trading sessions as well as daytrading and I still don't see RXSD as qualifying as a candidate. I'll give it more time and hope it does a 'WWW','CKSG' or 'BOBJY' or even 'AMFM' routine in the next few weeks, but I doubt it. I used to bullish on RXSD and have held it since it was 4... but I sold it finally last quarter after the shorts were ripping it apart.